RNA-based biopharmaceuticals, which includes therapeutics and vaccines, is a relatively new class of treatment and prophylactic for a number of chronic and rare diseases, including cancer, diabetes, tuberculosis and certaincardiovascular conditions.
RNA-based biopharmaceuticals are a relatively new class of therapies that are demonstrating significant growth and potential for the treatment and prevention of chronic and rare diseases.
Market Analysis and Insights: Global RNA-Based Therapeutics and Vaccines Market
The global RNA-Based Therapeutics and Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global RNA-Based Therapeutics and Vaccines Scope and Market Size
RNA-Based Therapeutics and Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global RNA-Based Therapeutics and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Alnylam Pharmaceuticals
Arbutus Biopharma
Arrowhead Pharmaceuticals
BioNTech
CureVac
Dicerna Pharmaceuticals
Regulus Therapeutics
Marina Biotech
MiRagen Therapeutics
Moderna Therapeutics
Quark Pharmaceuticals
Roche
Sylentis
RNA-Based Therapeutics and Vaccines Breakdown Data by Type
RNA-Based Therapeutics
RNA-Based Vaccines
RNA-Based Therapeutics and Vaccines Breakdown Data by Application
Oncology
Immunology
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Genetic Diseases
Others
RNA-based biopharmaceuticals are a relatively new class of therapies that are demonstrating significant growth and potential for the treatment and prevention of chronic and rare diseases.
Market Analysis and Insights: Global RNA-Based Therapeutics and Vaccines Market
The global RNA-Based Therapeutics and Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global RNA-Based Therapeutics and Vaccines Scope and Market Size
RNA-Based Therapeutics and Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global RNA-Based Therapeutics and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Alnylam Pharmaceuticals
Arbutus Biopharma
Arrowhead Pharmaceuticals
BioNTech
CureVac
Dicerna Pharmaceuticals
Regulus Therapeutics
Marina Biotech
MiRagen Therapeutics
Moderna Therapeutics
Quark Pharmaceuticals
Roche
Sylentis
RNA-Based Therapeutics and Vaccines Breakdown Data by Type
RNA-Based Therapeutics
RNA-Based Vaccines
RNA-Based Therapeutics and Vaccines Breakdown Data by Application
Oncology
Immunology
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Genetic Diseases
Others
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by RNA-Based Therapeutics and Vaccines Revenue
1.4 Market by Type
1.4.1 Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 RNA-Based Therapeutics
1.4.3 RNA-Based Vaccines
1.5 Market by Application
1.5.1 Global RNA-Based Therapeutics and Vaccines Market Share by Application: 2020 VS 2026
1.5.2 Oncology
1.5.3 Immunology
1.5.4 Ophthalmology
1.5.5 Cardiovascular Diseases
1.5.6 Infectious Diseases
1.5.7 Genetic Diseases
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global RNA-Based Therapeutics and Vaccines Market Perspective (2015-2026)
2.2 Global RNA-Based Therapeutics and Vaccines Growth Trends by Regions
2.2.1 RNA-Based Therapeutics and Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 RNA-Based Therapeutics and Vaccines Historic Market Share by Regions (2015-2020)
2.2.3 RNA-Based Therapeutics and Vaccines Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 RNA-Based Therapeutics and Vaccines Market Growth Strategy
2.3.6 Primary Interviews with Key RNA-Based Therapeutics and Vaccines Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top RNA-Based Therapeutics and Vaccines Players by Market Size
3.1.1 Global Top RNA-Based Therapeutics and Vaccines Players by Revenue (2015-2020)
3.1.2 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Players (2015-2020)
3.1.3 Global RNA-Based Therapeutics and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio
3.2.1 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by RNA-Based Therapeutics and Vaccines Revenue in 2019
3.3 RNA-Based Therapeutics and Vaccines Key Players Head office and Area Served
3.4 Key Players RNA-Based Therapeutics and Vaccines Product Solution and Service
3.5 Date of Enter into RNA-Based Therapeutics and Vaccines Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global RNA-Based Therapeutics and Vaccines Historic Market Size by Type (2015-2020)
4.2 Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
5.2 Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
6.2 RNA-Based Therapeutics and Vaccines Key Players in North America (2019-2020)
6.3 North America RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
6.4 North America RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
7 Europe
7.1 Europe RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
7.2 RNA-Based Therapeutics and Vaccines Key Players in Europe (2019-2020)
7.3 Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
7.4 Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
8 China
8.1 China RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
8.2 RNA-Based Therapeutics and Vaccines Key Players in China (2019-2020)
8.3 China RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
8.4 China RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
9 Japan
9.1 Japan RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
9.2 RNA-Based Therapeutics and Vaccines Key Players in Japan (2019-2020)
9.3 Japan RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
9.4 Japan RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
10.2 RNA-Based Therapeutics and Vaccines Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
10.4 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
11 India
11.1 India RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
11.2 RNA-Based Therapeutics and Vaccines Key Players in India (2019-2020)
11.3 India RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
11.4 India RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
12.2 RNA-Based Therapeutics and Vaccines Key Players in Central & South America (2019-2020)
12.3 Central & South America RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
12.4 Central & South America RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Alnylam Pharmaceuticals
13.1.1 Alnylam Pharmaceuticals Company Details
13.1.2 Alnylam Pharmaceuticals Business Overview
13.1.3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
13.1.4 Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020))
13.1.5 Alnylam Pharmaceuticals Recent Development
13.2 Arbutus Biopharma
13.2.1 Arbutus Biopharma Company Details
13.2.2 Arbutus Biopharma Business Overview
13.2.3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Introduction
13.2.4 Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.2.5 Arbutus Biopharma Recent Development
13.3 Arrowhead Pharmaceuticals
13.3.1 Arrowhead Pharmaceuticals Company Details
13.3.2 Arrowhead Pharmaceuticals Business Overview
13.3.3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
13.3.4 Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.3.5 Arrowhead Pharmaceuticals Recent Development
13.4 BioNTech
13.4.1 BioNTech Company Details
13.4.2 BioNTech Business Overview
13.4.3 BioNTech RNA-Based Therapeutics and Vaccines Introduction
13.4.4 BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.4.5 BioNTech Recent Development
13.5 CureVac
13.5.1 CureVac Company Details
13.5.2 CureVac Business Overview
13.5.3 CureVac RNA-Based Therapeutics and Vaccines Introduction
13.5.4 CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.5.5 CureVac Recent Development
13.6 Dicerna Pharmaceuticals
13.6.1 Dicerna Pharmaceuticals Company Details
13.6.2 Dicerna Pharmaceuticals Business Overview
13.6.3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
13.6.4 Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.6.5 Dicerna Pharmaceuticals Recent Development
13.7 Regulus Therapeutics
13.7.1 Regulus Therapeutics Company Details
13.7.2 Regulus Therapeutics Business Overview
13.7.3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Introduction
13.7.4 Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.7.5 Regulus Therapeutics Recent Development
13.8 Marina Biotech
13.8.1 Marina Biotech Company Details
13.8.2 Marina Biotech Business Overview
13.8.3 Marina Biotech RNA-Based Therapeutics and Vaccines Introduction
13.8.4 Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.8.5 Marina Biotech Recent Development
13.9 MiRagen Therapeutics
13.9.1 MiRagen Therapeutics Company Details
13.9.2 MiRagen Therapeutics Business Overview
13.9.3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Introduction
13.9.4 MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.9.5 MiRagen Therapeutics Recent Development
13.10 Moderna Therapeutics
13.10.1 Moderna Therapeutics Company Details
13.10.2 Moderna Therapeutics Business Overview
13.10.3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Introduction
13.10.4 Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.10.5 Moderna Therapeutics Recent Development
13.11 Quark Pharmaceuticals
10.11.1 Quark Pharmaceuticals Company Details
10.11.2 Quark Pharmaceuticals Business Overview
10.11.3 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
10.11.4 Quark Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
10.11.5 Quark Pharmaceuticals Recent Development
13.12 Roche
10.12.1 Roche Company Details
10.12.2 Roche Business Overview
10.12.3 Roche RNA-Based Therapeutics and Vaccines Introduction
10.12.4 Roche Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
10.12.5 Roche Recent Development
13.13 Sylentis
10.13.1 Sylentis Company Details
10.13.2 Sylentis Business Overview
10.13.3 Sylentis RNA-Based Therapeutics and Vaccines Introduction
10.13.4 Sylentis Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
10.13.5 Sylentis Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by RNA-Based Therapeutics and Vaccines Revenue
1.4 Market by Type
1.4.1 Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 RNA-Based Therapeutics
1.4.3 RNA-Based Vaccines
1.5 Market by Application
1.5.1 Global RNA-Based Therapeutics and Vaccines Market Share by Application: 2020 VS 2026
1.5.2 Oncology
1.5.3 Immunology
1.5.4 Ophthalmology
1.5.5 Cardiovascular Diseases
1.5.6 Infectious Diseases
1.5.7 Genetic Diseases
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global RNA-Based Therapeutics and Vaccines Market Perspective (2015-2026)
2.2 Global RNA-Based Therapeutics and Vaccines Growth Trends by Regions
2.2.1 RNA-Based Therapeutics and Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 RNA-Based Therapeutics and Vaccines Historic Market Share by Regions (2015-2020)
2.2.3 RNA-Based Therapeutics and Vaccines Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 RNA-Based Therapeutics and Vaccines Market Growth Strategy
2.3.6 Primary Interviews with Key RNA-Based Therapeutics and Vaccines Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top RNA-Based Therapeutics and Vaccines Players by Market Size
3.1.1 Global Top RNA-Based Therapeutics and Vaccines Players by Revenue (2015-2020)
3.1.2 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Players (2015-2020)
3.1.3 Global RNA-Based Therapeutics and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio
3.2.1 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by RNA-Based Therapeutics and Vaccines Revenue in 2019
3.3 RNA-Based Therapeutics and Vaccines Key Players Head office and Area Served
3.4 Key Players RNA-Based Therapeutics and Vaccines Product Solution and Service
3.5 Date of Enter into RNA-Based Therapeutics and Vaccines Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global RNA-Based Therapeutics and Vaccines Historic Market Size by Type (2015-2020)
4.2 Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
5.2 Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
6.2 RNA-Based Therapeutics and Vaccines Key Players in North America (2019-2020)
6.3 North America RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
6.4 North America RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
7 Europe
7.1 Europe RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
7.2 RNA-Based Therapeutics and Vaccines Key Players in Europe (2019-2020)
7.3 Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
7.4 Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
8 China
8.1 China RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
8.2 RNA-Based Therapeutics and Vaccines Key Players in China (2019-2020)
8.3 China RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
8.4 China RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
9 Japan
9.1 Japan RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
9.2 RNA-Based Therapeutics and Vaccines Key Players in Japan (2019-2020)
9.3 Japan RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
9.4 Japan RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
10.2 RNA-Based Therapeutics and Vaccines Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
10.4 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
11 India
11.1 India RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
11.2 RNA-Based Therapeutics and Vaccines Key Players in India (2019-2020)
11.3 India RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
11.4 India RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
12.2 RNA-Based Therapeutics and Vaccines Key Players in Central & South America (2019-2020)
12.3 Central & South America RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
12.4 Central & South America RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Alnylam Pharmaceuticals
13.1.1 Alnylam Pharmaceuticals Company Details
13.1.2 Alnylam Pharmaceuticals Business Overview
13.1.3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
13.1.4 Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020))
13.1.5 Alnylam Pharmaceuticals Recent Development
13.2 Arbutus Biopharma
13.2.1 Arbutus Biopharma Company Details
13.2.2 Arbutus Biopharma Business Overview
13.2.3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Introduction
13.2.4 Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.2.5 Arbutus Biopharma Recent Development
13.3 Arrowhead Pharmaceuticals
13.3.1 Arrowhead Pharmaceuticals Company Details
13.3.2 Arrowhead Pharmaceuticals Business Overview
13.3.3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
13.3.4 Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.3.5 Arrowhead Pharmaceuticals Recent Development
13.4 BioNTech
13.4.1 BioNTech Company Details
13.4.2 BioNTech Business Overview
13.4.3 BioNTech RNA-Based Therapeutics and Vaccines Introduction
13.4.4 BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.4.5 BioNTech Recent Development
13.5 CureVac
13.5.1 CureVac Company Details
13.5.2 CureVac Business Overview
13.5.3 CureVac RNA-Based Therapeutics and Vaccines Introduction
13.5.4 CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.5.5 CureVac Recent Development
13.6 Dicerna Pharmaceuticals
13.6.1 Dicerna Pharmaceuticals Company Details
13.6.2 Dicerna Pharmaceuticals Business Overview
13.6.3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
13.6.4 Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.6.5 Dicerna Pharmaceuticals Recent Development
13.7 Regulus Therapeutics
13.7.1 Regulus Therapeutics Company Details
13.7.2 Regulus Therapeutics Business Overview
13.7.3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Introduction
13.7.4 Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.7.5 Regulus Therapeutics Recent Development
13.8 Marina Biotech
13.8.1 Marina Biotech Company Details
13.8.2 Marina Biotech Business Overview
13.8.3 Marina Biotech RNA-Based Therapeutics and Vaccines Introduction
13.8.4 Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.8.5 Marina Biotech Recent Development
13.9 MiRagen Therapeutics
13.9.1 MiRagen Therapeutics Company Details
13.9.2 MiRagen Therapeutics Business Overview
13.9.3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Introduction
13.9.4 MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.9.5 MiRagen Therapeutics Recent Development
13.10 Moderna Therapeutics
13.10.1 Moderna Therapeutics Company Details
13.10.2 Moderna Therapeutics Business Overview
13.10.3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Introduction
13.10.4 Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.10.5 Moderna Therapeutics Recent Development
13.11 Quark Pharmaceuticals
10.11.1 Quark Pharmaceuticals Company Details
10.11.2 Quark Pharmaceuticals Business Overview
10.11.3 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
10.11.4 Quark Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
10.11.5 Quark Pharmaceuticals Recent Development
13.12 Roche
10.12.1 Roche Company Details
10.12.2 Roche Business Overview
10.12.3 Roche RNA-Based Therapeutics and Vaccines Introduction
10.12.4 Roche Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
10.12.5 Roche Recent Development
13.13 Sylentis
10.13.1 Sylentis Company Details
10.13.2 Sylentis Business Overview
10.13.3 Sylentis RNA-Based Therapeutics and Vaccines Introduction
10.13.4 Sylentis Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
10.13.5 Sylentis Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
